ZOMIG NASAL SPRAY 5MG

Zomig Nasal Spray is administered as a single dose into one nostril. Zomig Nasal Spray provides particularly rapid onset of relief of a migraine with the first signs of efficacy apparent within 15 minutes of dosing.

Zomig Nasal Spray provides an alternative non–oral formulation of zolmitriptan to that of Zomig oral tablets and orodispersible tablets. This formulation may also be beneficial where a non–oral route of treatment is either needed or preferred.

If symptoms persist or return within 24 hours a second dose has been shown to be effective. If a second dose is required, it should not be taken within 2 hours of the initial dose.

Zomig Nasal Spray is effective whenever the nasal spray is administered during a migraine attack; although it is advisable that Zomig Nasal Spray is taken as early as possible after the onset of a migraine headache.

In the event of recurrent attacks, it is recommended that the total intake of Zomig Nasal Spray in a 24 hour period should not exceed 10 mg.

Zomig Nasal Spray is not indicated for prophylaxis of a migraine.

Patient Information leaflet